Celldex Therapeutics
www.celldex.comCelldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.
Read more
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.
Read more
Country
State
New Jersey
Industry
Estimated Revenue
$5,000,000 to $10,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President , Manufacturing Operations and Supply at Celldex Therapeutics
Email ****** @****.comPhone (***) ****-****Executive Director , Process Research and Development
Email ****** @****.comPhone (***) ****-****Founder , Member of Board of Directors
Email ****** @****.comPhone (***) ****-****Clinical Scientist , Director
Email ****** @****.comPhone (***) ****-****
Technologies
(16)
We'll help you understand if Lusha can solve your business needs.
